Interestingly, a dual role for DNA-PKcs has been further suggested in preclinical models, as a tumor suppressor in premalignant stages maintaining genome integrity; while in an aggressive and advanced stage, DNA-PKcs could indicate high genomic instability, thus acting as an oncogenic driver23. This evidence concerns the gene PRKDC and neoplasm.